Johnson & Johnson said in a statement late Thursday that its single-shot Covid-19 vaccine showed strong promise against the Delta variant and other emerging strains and also provided durable protection against the infection more broadly.

Data showed that the durability of immune response for recipients of its vaccine lasted at least eight months, the healthcare company said, adding that its vaccine was 85 percent effective and could also help prevent hospitalisation and death.

First identified in India...